Historical development of brequinar sodium as a new immunosuppressive drug for transplantation.
Makowka
L
L
Department of Surgery, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Chapman
F
F
Cramer
D V
DV
D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D014181:Transplantation Immunology / Q000187:drug effects*; D011798:Quinaldines
D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; C046943:brequinar; D011798:Quinaldines